CUHK Jockey Club HOPE 4 Care Programme - Hand of Hope

October 19, 2022 updated by: Raymond KY Tong, Chinese University of Hong Kong

Jockey Club Tech-based Stroke Rehabilitation Programme - Hand of Hope

The Hong Kong Jockey Club Charities Trust has supported CUHK to launch a three-year project 'CUHK Jockey Club HOPE4Care Programme' to implement four evidence-based advanced rehabilitation technologies in 40 local elderly day care centres and rehabilitation centres, to benefit the community.

The interactive intention-driven hand training robotic system is used for neuromuscular rehabilitation of the hand and forearm. This can help stroke survivors to regain their hand functions through motor relearning.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

111

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hong Kong
      • Hong Kong, Hong Kong
        • Department of Biomedical Engineering, The Chinese University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • at least six months after the onset of a unilateral ischemic brain injury or intracerebral haemorrhage
  • upper-limb motor impairments due to stroke
  • metacarpophalangeal and proximal interphalangeal joints of fingers can be extended to 180 degree passively
  • spasticity during extension at the finger joints is lower than 3 as measured by the Modified Ashworth Scale
  • detectable voluntary EMG signals from the flexor digitorum and extensor digitorum muscles of the paretic hand
  • have sufficient cognition to follow the experimental instructions

Exclusion Criteria:

  • have other neurological, neuromuscular, and orthopedic diseases
  • have shoulder or arm contracture/pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EMG-driven
The hand training system functions as a biofeedback device which surface electromyography (EMG) sensors are used to capture the user's own muscle signals to activate the system for moving his/her paretic hand.
Device: EMG-driven
The EMG signals are processed and can be visualized with visual feedback to make sure the user actively engaging throughout a therapy session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Action Research Arm Test (ARAT)
Time Frame: 3-month follow-up
3-month follow-up
Fugl-Meyer Assessment Upper Extremity (FMA-UE)
Time Frame: 3-month follow-up
3-month follow-up
Wolf Motor Function Test (WMFT)
Time Frame: 3-month follow-up
3-month follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
Modified Ashworth Scale (MAS)
Time Frame: 3-month follow-up
3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chinese University of Hong Kong

Collaborators

The Hong Kong Jockey Club Charities Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

July 31, 2022

Study Completion (Actual)

July 31, 2022

Study Registration Dates

First Submitted

December 20, 2018

First Submitted That Met QC Criteria

January 15, 2019

First Posted (Actual)

January 17, 2019

Study Record Updates

Last Update Posted (Actual)

October 21, 2022

Last Update Submitted That Met QC Criteria

October 19, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2018.399

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on EMG-driven

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe